Loading...
XNAS
IMCC
Market cap497kUSD
Jul 10, Last price  
0.16USD
Name

IM Cannabis Corp

Chart & Performance

D1W1MN
XNAS:IMCC chart
P/E
—
P/S
0.01
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.91%
Rev. gr., 5y
28.06%
Revenues
55m
+1.30%
00000000004,393,0005,197,0005,197,0009,074,00015,890,00034,053,00054,335,00048,804,00054,031,00054,731,000
Net income
-11m
L+6.93%
-762,000-1,414,000-1,324,125-669,181-519,773-5,374,000-228,344-37,687-45,613-15,750538,0001,683,0001,683,000-7,292,000-28,698,000-17,763,000-188,890,000-9,498,000-10,585,000-11,319,000
CFO
5m
P
-386,294-433,971-1,171,366-527,852-632,559-434,090-218,720-82,884-205,701-26,5960525,000-431,000-5,959,000-7,919,000-34,372,000-12,640,000-8,075,000-1,077,0004,716,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

IM Cannabis Corp. is engaged in the cultivation, processing, and supply of medical cannabis products across its operational territories of Israel, Germany, and Canada. The company's product portfolio features cannabis flowers and distinctive, strain-specific extracts marketed under its IMC brand. Additionally, it offers dried flower, pre-rolls, and pressed hash through its WAGNERS and Highland Grow labels. IM Cannabis Corp. caters to a diverse customer base, including medical patients and adult-use recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
URL
https://imcannabis.com/
IPO date
Oct 21, 1983
Employees
283
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122019‑042018‑122018‑042017‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT